Condition: Breast Cancer · Capsular Contracture Associated With Breast Implant · Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle
This study evaluates the capacity of the NovaGray RILA Breast® test to predict the toxicity linked to radiotherapy and the impact of implant breast reconstruction.
This description comes directly from the study's public registry record.
Aurore MOUSSION · 04 67 61 31 02 · DRCI-icm105@icm.unicancer.fr
Emmanuelle TEXIER · 04 67 61 31 02 · DRCI-icm105@icm.unicancer.fr
Always discuss trial participation with your own doctor first.
| Centre Georges François Leclerc | Dijon, France | Recruiting |
| Centre Oscar Lambret | Lille, France | Recruiting |
| Centre Léon Bérard | Lyon, France | Recruiting |
| Institut Paoli Calmette | Marseille, France | Recruiting |
| Institut du Cancer de Montpellier | Montpellier, France | Recruiting |
| centre Antoine Lacassagne | Nice, France | Recruiting |
| Hôpital Tenon | Paris, France | Recruiting |
| Institut de Cancérologie de l'Ouest | Saint-Herblain, France | Recruiting |
| Institut Claudius Regaud | Toulouse, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04342546